Serum levels of TNF-α, IL-6, IL-1β, IL-17A had no significant differences between the two groups, however the rates of high IL-17A level > 5 ng/ml and high IL-1β level > 0.4 ng/ml were increased in the non-good response group with slightly significant differences.
← all excerpts
Serum GM-CSF level is a predictor of treatment response to tocilizumab in rheumatoid arthritis patients: a prospective observational cohort study.
1
—
—